Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
Lower risk for developing chemosensory loss observed with alpha, delta, and omicron variants
Viral Infections
FDA Declines EUA Request for Fluvoxamine for COVID-19 Treatment
The totality of the evidence led the FDA to determine that the criteria for issuing an EUA had not been met.
mRNA-1273 Induces Stronger Response Than BNT162b2 for Immunosuppressed
Findings seen in immunosuppressed patients with rheumatic and musculoskeletal diseases, solid organ transplant recipients
Persistent Viral Shedding Common in Hospitalized COVID-19 Patients
Persistent viral shedding associated with in-hospital delirium and increased six-month mortality
Lenacapavir Reduces Viral Load in Multidrug-Resistant HIV-1 Infection
Reduction in viral load from baseline greater with lenacapavir versus placebo among those with multidrug-resistant HIV-1 infection
Olumiant Approved for COVID-19 Treatment in Hospitalized Adults
The approval was based on data from the phase 3 ACTT-2 and COV-BARRIER studies.
Rare Cases of COVID-19 Relapse Seen With Pfizer Pill
Reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid
NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine
The phase 1 trial is expected to last four years and enroll 40 participants
COVID-19 Drug Paxlovid Might Also Fight Long COVID
Series of case reports shows some success with Paxlovid in treating patients with long COVID
CDC Reports First American With New Bird Flu
However, the CDC notes that the risk to the general public is still low
